N-PORT filing recap · June 2023

What did Ariel Appreciation Fund buy in June 2023?

Reported stock-position changes between this filing and the previous one. These are Ariel Appreciation Fund's own holdings, not the firm's.

Stock value

$1.08B

Positions

Estimated turnover

25.6%

Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.

New positions

CLBCore Laboratories Inc.$32.34Mreported value+1.39M shares MSGEMadison Square Garden Entertainment Corp.$18.48Mreported value+549.8K shares CGCarlyle Group Inc.$16.94Mreported value+530.1K shares PARAParamount Global$13.99Mreported value+879.2K shares

Increased positions

MATMattel Inc /de/$43.05Mreported value+188.1K shares+9.3%NTRSNorthern Trust Corp$39.39Mreported value+11.9K shares+2.3%SCHWSchwab Charles Corp$35.55Mreported value+27.1K shares+4.5%CRLCharles River Laboratories International, Inc.$35.44Mreported value+19.5K shares

Reduced positions

LHLabcorp Holdings Inc.$41.29Mreported value-9.0K shares-5.0%GSThe Goldman Sachs Group, Inc.$39.19Mreported value-22.2K shares-15.4%KMXCarmax, Inc.$38.27Mreported value-71.3K shares-13.5%KMTKennametal Inc$34.17Mreported value-85.5K shares

Exited positions

CLBCore Laboratories Inc.$28.70Mprior reported value-1.30M shares-100.0%CAHCardinal Health, Inc.$11.51Mprior reported value-152.4K shares-100.0%